Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Medtronic
Moodys
Harvard Business School
Dow
Merck
AstraZeneca

Last Updated: December 9, 2019

DrugPatentWatch Database Preview

MANNITOL 20% Drug Profile

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

When do Mannitol 20% patents expire, and when can generic versions of Mannitol 20% launch?

Mannitol 20% is a drug marketed by B Braun, Hospira, Miles, and Icu Medical Inc. and is included in six NDAs.

The generic ingredient in MANNITOL 20% is mannitol. There are eighteen drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the mannitol profile page.

Summary for MANNITOL 20%
Drug patent expirations by year for MANNITOL 20%
Recent Clinical Trials for MANNITOL 20%

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Allergy- and pulmonary Clinic, Vanloese.Phase 4
Lund UniversityPhase 4
ALK-Abelló A/SPhase 4

See all MANNITOL 20% clinical trials

Pharmacology for MANNITOL 20%
Drug ClassOsmotic Diuretic
Mechanism of ActionOsmotic Activity
Physiological EffectIncreased Diuresis

US Patents and Regulatory Information for MANNITOL 20%

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
B Braun MANNITOL 20% mannitol INJECTABLE;INJECTION 014738-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Miles MANNITOL 20% mannitol INJECTABLE;INJECTION 016472-004 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
B Braun MANNITOL 20% mannitol INJECTABLE;INJECTION 016080-004 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
McKinsey
Boehringer Ingelheim
Moodys
Merck
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.